Advanced in WT1-Related Wilms Tumor Syndromes

Dr. Lambros Stamatakis

Urology
MedStar Health
Medstar Medical Group Ii LLC
1133 21st St Nw, Medstar At Lafayette Centr, 
Washington, DC 
Accepting New Patients
Offers Telehealth

Advanced in WT1-Related Wilms Tumor Syndromes
MedStar Health
Medstar Medical Group Ii LLC
1133 21st St Nw, Medstar At Lafayette Centr, 
Washington, DC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lambros Stamatakis is an Urologist in Washington, Washington, D.c.. Dr. Stamatakis is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Stamatakis is currently accepting new patients.

His clinical research consists of co-authoring 46 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in MD
Hospital Affiliations
Medstar Georgetown University Hospital
Medstar Washington Hospital Center
Medstar Saint Mary's Hospital
Medstar Southern Maryland Hospital Center
Languages Spoken
English
Greek
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

MEDSTAR MEDICAL GROUP II LLC
1133 21st St Nw, Medstar At Lafayette Centr, Washington, DC 20036
Call: 202-416-2000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Gemcitabine Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2025
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3
Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
Enrollment Status: Active_not_recruiting
Publish Date: February 21, 2025
Intervention Type: Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

46 Total Publications

Synchronous papillary renal neoplasm with reverse polarity and multilocular cystic renal neoplasm of low malignant potential in unilateral kidney: case report with molecular analysis and literature review.
Synchronous papillary renal neoplasm with reverse polarity and multilocular cystic renal neoplasm of low malignant potential in unilateral kidney: case report with molecular analysis and literature review.
Journal: Frontiers in oncology
Published: April 03, 2025
View All 46 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael W. Phelan
Urology | General Surgery
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael W. Phelan
Urology | General Surgery

University Of Maryland Surgical Associates PA

419 W Redwood St, Fl 3, 
Baltimore, MD 
 (34.9 miles away)
410-328-5300
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Phelan is an Urologist and a General Surgeon in Baltimore, Maryland. Dr. Phelan is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Phelan is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ross E. Krasnow
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ross E. Krasnow
Urology

Medstar Medical Group Ii LLC

1145 19th St Nw, 311 Mmg At 19th Street Nw, 
Washington, DC 
 (0.2 miles away)
202-429-2401
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ross Krasnow is an Urologist in Washington, Washington, D.c.. Dr. Krasnow has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Clear Cell Sarcoma, Nephrectomy, and Cystectomy. Dr. Krasnow is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Rian J. Dickstein
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Rian J. Dickstein
Urology

Chesapeake Urology Associates LLC

6535 N Charles St, Suite 625, 
Baltimore, MD 
 (40.3 miles away)
410-825-5454
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rian Dickstein is an Urologist in Baltimore, Maryland. Dr. Dickstein is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Hydronephrosis, Ureteroscopy, and Nephrectomy. Dr. Dickstein is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Stamatakis's expertise for a condition
ConditionClose
  • Elite
  • Bladder Cancer
    Dr. Stamatakis is
    Elite
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Distinguished
  • Muscle Invasive Bladder Cancer
    Dr. Stamatakis is
    Distinguished
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
  • Non-Muscle Invasive Bladder Cancer
    Dr. Stamatakis is
    Distinguished
    . Learn about Non-Muscle Invasive Bladder Cancer.
    See more Non-Muscle Invasive Bladder Cancer experts
  • Renal Cell Carcinoma (RCC)
    Dr. Stamatakis is
    Distinguished
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
  • Upper Tract Urothelial Carcinoma (UTUC)
    Dr. Stamatakis is
    Distinguished
    . Learn about Upper Tract Urothelial Carcinoma (UTUC).
    See more Upper Tract Urothelial Carcinoma (UTUC) experts
  • Urothelial Cancer
    Dr. Stamatakis is
    Distinguished
    . Learn about Urothelial Cancer.
    See more Urothelial Cancer experts
  • Advanced
  • Bilateral Hydronephrosis
    Dr. Stamatakis is
    Advanced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Chromophobe Renal Cell Carcinoma
    Dr. Stamatakis is
    Advanced
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Clear Cell Sarcoma
    Dr. Stamatakis is
    Advanced
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Cystectomy
    Dr. Stamatakis is
    Advanced
    . Learn about Cystectomy.
    See more Cystectomy experts
  • Enlarged Prostate (BPH)
    Dr. Stamatakis is
    Advanced
    . Learn about Enlarged Prostate (BPH).
    See more Enlarged Prostate (BPH) experts
  • Familial Wilms Tumor 2
    Dr. Stamatakis is
    Advanced
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
View All 19 Advanced Conditions
  • Experienced
  • Bladder Outlet Obstruction
    Dr. Stamatakis is
    Experienced
    . Learn about Bladder Outlet Obstruction.
    See more Bladder Outlet Obstruction experts
  • Bladder Reconstruction
    Dr. Stamatakis is
    Experienced
    . Learn about Bladder Reconstruction.
    See more Bladder Reconstruction experts
  • Boils
    Dr. Stamatakis is
    Experienced
    . Learn about Boils.
    See more Boils experts
  • Carbuncle
    Dr. Stamatakis is
    Experienced
    . Learn about Carbuncle.
    See more Carbuncle experts
  • Choriocarcinoma
    Dr. Stamatakis is
    Experienced
    . Learn about Choriocarcinoma.
    See more Choriocarcinoma experts
  • Classical Hodgkin Lymphoma
    Dr. Stamatakis is
    Experienced
    . Learn about Classical Hodgkin Lymphoma.
    See more Classical Hodgkin Lymphoma experts
View All 32 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved